This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 MD Barber , JA Ross & KC Fearon (1999) Cancer cachexia. Surg Oncol 8, 133–141.
2 M Larkin (1998) Thwarting the dwindling progression of cachexia. Lancet 351, 1336.
3 MJ Tisdale (1997) Biology of cachexia. J Natl Cancer Inst 89, 1763–1773.
4 G Azhar & JY Wei (2006) Nutrition and cardiac cachexia. Curr Opin Clin Nutr Metab Care 9, 18–23.
6 WD Dewys , C Begg , PT Lavin , (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69, 491–497.
7 DP Kotler , AR Tierney , JA Culpepper-Morgan , (1990) Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 14, 454–458.
8 SD Anker & R Sharma (2002) The syndrome of cardiac cachexia. Int J Cardiol 85, 51–66.
9 MJ Delano & LL Moldawer (2006) The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract 21, 68–81.
10 M Klaude , K Fredriksson , I Tjader , (2007) Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Colch) 112, 499–506.
12 J Büntzel & K Küttner (1995) Value of megestrol acetate in treatment of cachexia in head–neck tumors (article in German). Laryngorhinootologie 74, 504–507.
13 J Lees (1999) Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care (Engl) 8, 133–136.
14 JA Palesty & SJ Dudrick (2003) What we have learned about cachexia in gastrointestinal cancer. Dig Dis 21, 198–213.
15 RT Jagoe & AL Goldberg (2001) What do we really know about the ubiquitin–proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 4, 183–190.
16 MD Gomes , SH Lecker , RT Jagoe , (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 98, 14440–14445.
17 SC Bodine , E Latres , S Baumhueter , (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704–1708.
18 CJ Wray , JMV Mammen , DD Hershko , (2003) Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 35, 698–705.
19 SH Lecker , RT Jagoe , A Gilbert , (2004) Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18, 39–51.
20 MJM Dehoux , RP van Beneden , L Fernandez-Celemin , (2003) Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett 544, 214–217.
22 S Di Giovanni , A Molon , A Broccolini , (2004) Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 55, 195–206.
23 R Siddiqui , D Pandya , K Harvey , (2006) Nutrition modulation of cachexia/proteolysis. Nutr Clin Pract 21, 155–161.
26 A Inui (2002) Cancer anorexia–cachexia syndrome: current issues in research and management. CA Cancer J Clin 52, 72–91.
27 HP Ammon & MA Wahl (1991) Pharmacology of Curcuma longa. Planta Med 57, 1–7.
28 J Miquel , A Bernd , JM Sempere , (2002) The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 34, 37–46.
29 B Joe , M Vijaykumar & BR Lokesh (2004) Biological properties of curcumin – cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44, 97–111.
30 A Goel , AB Kunnumakkara & BB Aggarwal (2008) Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol 75, 787–809.
31 BB Aggarwal , S Shishodia , Y Takada , (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-κB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490–7498.
32 S Shishodia , MM Chaturvedi & BB Aggarwal (2007) Role of curcumin in cancer therapy. Curr Probl Cancer 31, 243–305.
33 NR Jana , P Dikshit , A Goswami , (2004) Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279, 11680–11685.
35 B Jin & Y-P Li (2007) Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J Cell Biochem 100, 960–969.
37 S Busquets , N Carbo , V Almendro , (2001) Curcumin, a natural product present in turmeric, decreases tumor growth but does not behave as an anticachectic compound in a rat model. Cancer Lett 167, 33–38.
39 RA Sharma , SA Euden , SL Platton , (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10, 6847–6854.
40 CD Lao , MTIV Ruffin , D Normolle , (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10.
42 TH Marczylo , RD Verschoyle , DN Cooke , (2007) Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60, 171–177.
43 AS Whitehouse & MJ Tisdale (2003) Increased expression of the ubiquitin–proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-κB. Br J Cancer 89, 1116–1122.
46 D Cai , JD Frantz , NE Tawa Jr, (2004) IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119, 285–298.
48 HB Breen & NJ Espat (2004) The ubiquitin–proteasome proteolysis pathway: potential target for disease intervention. JPEN J Parenter Enteral Nutr 28, 272–277.
49 M Llovera , C Garcia-Martinez , N Agell , (1995) Muscle wasting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 61, 138–141.
50 PO Hasselgren (1999) Role of the ubiquitin–proteasome pathway in sepsis-induced muscle catabolism. Mol Biol Rep 26, 71–76.
51 M Llovera , N Carbo , J Lopez-Soriano , (1998) Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. Cancer Lett 133, 83–87.
52 M Llovera , C Garcia-Martinez , N Agell , (1997) TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230, 238–241.
53 C Garcia-Martinez , M Llovera , N Agell , (1994) Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-α. Biochem Biophys Res Commun 201, 682–686.
56 TN Stitt , D Drujan , BA Clarke , (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14, 395–403.
57 M Sandri , C Sandri , A Gilbert , (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399–412.
58 E Latres , AR Amini , AA Amini , (2005) Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280, 2737–2744.
59 Y-P Li , Y Chen , J John , (2005) TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19, 362–370.
60 Y-P Li , SH Lecker , Y Chen , (2003) TNF-α increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17, 1048–1057.
62 V Poylin , MU Fareed , P O'Neal , (2008) The NF-κB inhibitor curcumin blocks sepsis-induced muscle proteolysis. Mediators Inflamm 2008, 317851.
64 WJ Durham , S Arbogast , E Gerken , (2006) Progressive nuclear factor-κB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle Nerve 34, 298–303.
65 Y Carter , G Liu , J Yang , (2003) Sublethal hemorrhage induces tolerance in animals exposed to cecal ligation and puncture by altering p38, p44/42, and SAPK/JNK MAP kinase activation. Surg Infect (Larchmt) 4, 17–27.